AU5907800A - Membrane-associated and secreted proteins and uses thereof - Google Patents

Membrane-associated and secreted proteins and uses thereof

Info

Publication number
AU5907800A
AU5907800A AU59078/00A AU5907800A AU5907800A AU 5907800 A AU5907800 A AU 5907800A AU 59078/00 A AU59078/00 A AU 59078/00A AU 5907800 A AU5907800 A AU 5907800A AU 5907800 A AU5907800 A AU 5907800A
Authority
AU
Australia
Prior art keywords
membrane
secreted proteins
secreted
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59078/00A
Inventor
Thomas M. Barnes
Samantha J. Busfield
Christopher C Fraser
Paul Myers
John D. Sharp
Nicholas Wrighton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU5907800A publication Critical patent/AU5907800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU59078/00A 1999-06-30 2000-06-29 Membrane-associated and secreted proteins and uses thereof Abandoned AU5907800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34546499A 1999-06-30 1999-06-30
US09345464 1999-06-30
PCT/US2000/018198 WO2001000673A1 (en) 1999-06-30 2000-06-29 Membrane-associated and secreted proteins and uses thereof

Publications (1)

Publication Number Publication Date
AU5907800A true AU5907800A (en) 2001-01-31

Family

ID=23355165

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59078/00A Abandoned AU5907800A (en) 1999-06-30 2000-06-29 Membrane-associated and secreted proteins and uses thereof

Country Status (2)

Country Link
AU (1) AU5907800A (en)
WO (1) WO2001000673A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
AU3300301A (en) * 2000-01-25 2001-08-07 Hyseq Inc Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
US20050208498A1 (en) * 2000-01-25 2005-09-22 Nuvelo, Inc. Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
WO2002081510A2 (en) * 2001-01-18 2002-10-17 Curagen Corporation Proteins, polynucleotides encoding them and methods of using the same
CA2443909A1 (en) 2001-04-11 2002-10-24 Bristol-Myers Squibb Company Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
PE20120341A1 (en) 2008-12-09 2012-04-24 Genentech Inc ANTI-PD-L1 ANTIBODIES AND ITS USE TO IMPROVE T-CELL FUNCTION
CN114028549A (en) * 2016-02-19 2022-02-11 伊玛提克斯生物技术有限公司 Novel peptides and peptide compositions for immunotherapy of NHL and other cancers
US20230416334A1 (en) * 2020-11-10 2023-12-28 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Cell-penetrating peptides

Also Published As

Publication number Publication date
WO2001000673A8 (en) 2001-03-29
WO2001000673A9 (en) 2002-07-25
WO2001000673A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
AU7602400A (en) Secreted proteins and uses thereof
AU1473501A (en) 21 human secreted proteins
AU1438001A (en) 27 human secreted proteins
AU1604401A (en) 18 human secreted proteins
AU1448701A (en) 15 human secreted proteins
AU1334101A (en) 19 human secreted proteins
AU2757500A (en) 33 human secreted proteins
AU6394400A (en) Secreted proteins and uses thereof
AU3517000A (en) 50 human secreted proteins
AU1918601A (en) 23 human secreted proteins
AU5907800A (en) Membrane-associated and secreted proteins and uses thereof
AU3628600A (en) 46 human secreted proteins
AU1916101A (en) 19 human secreted proteins
AU1342501A (en) 32 human secreted proteins
AU5750200A (en) Secreted proteins and uses thereof
AU3249300A (en) 47 human secreted proteins
AU3208700A (en) 33 human secreted proteins
AU3396600A (en) 49 human secreted proteins
AU3382800A (en) Secreted proteins and uses thereof
AU1449001A (en) 28 human secreted proteins
AU1190801A (en) Secreted proteins and uses thereof
WO2000069885A8 (en) Secreted proteins and uses thereof
AU1472801A (en) 24 human secreted proteins
AU3628700A (en) 49 human secreted proteins
AU5907200A (en) Secreted proteins and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase